On Friday October 10, U.S. Eastern Time, Daiichi Sankyo Company through its wholly-owned U.S. subsidiary, Charge Acquisition Corp., launched a tender offer to acquire the outstanding common stock of Ambit Biosciences Corp. for $15.00 per share plus ... Individual.com, 1 week ago
Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation - SearchBug, 1 week ago
DAIICHI SANKYO : Launches Tender Offer for Shares in Ambit Biosciences - 4 Traders, 1 week ago
3 images for "daiichi sankyo company"
Daiichi Sankyo Company Limited, a Japanese pharmaceutical company, and its generic subsidiary, Daiichi Sankyo Espha Co., Ltd., have submitted a supplemental new drug application, or sNDA, for the synthetic broad-spectrum oral antibacterial agent, ...Individual.com, 2 weeks ago Daiichi Sankyo seeks approval for TB drug in Japan Bio Spectrum Asia, 2 weeks ago Daiichi Sankyo Espha seeks Japanese nod for Cravit & levofloxacin tablets to treat pulmonary and other tuberculosis disorders PharmaBiz, 2 weeks ago Sun Pharma banks on Daiichi Sankyo to enter Japan market: Reports India Infoline, 2 months ago
Perosphere Inc. and Daiichi Sankyo Company, Limited have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse ...PharmaAsia, 2 weeks ago Perosphere enters third clinical trial collaboration agreement with Daiichi Sankyo PharmaBiz, 2 weeks ago Perosphere and Daiichi Sankyo collaborate on Ph III study of PER977 with edoxaban Pharma Letter, 2 weeks ago Perosphere and Daiichi Sankyo Enter into a Clinical Trial Collaboration Agreement for Phase 3 Studies of PER977 to Investigate Reversal of the Anticoagulant Activity of the Investigational Factor Xa-Inhibitor Edoxaban Scottrade, 2 weeks ago
Center for Connected Health and Daiichi Sankyo, Inc. Sign Agreement to Co-Develop a Mobile App to Support Patients with Atrial Fibrillation
BOSTON , Oct. 22, 2014 --The Center for Connected Health today announced a co-development agreement with Daiichi Sankyo, Inc. to create a mobile app to serve as a coaching platform for patients with atrial fibrillation who have been prescribed oral ...ITbriefing, 1 day ago Center for Connected Health, Daiichi Sankyo ink mobile app agreement Center Watch, 14 hours ago
(MarketLine via COMTEX News Network) -- Daiichi Sankyo Company, Limited, a research-based pharmaceutical company, has received approval from the Ministry of Health, Labour and Welfare in Japan for LIXIANA for the prevention of ischemic stroke and ...PredictWallStreet, 3 weeks ago
Ambit Biosciences Corp (NASDAQ:AMBI) Investor Alert: Lawsuit Filed to Halt Takeover by Daiichi Sankyo Company
A lawsuit was filed by investor in shares of Ambit Biosciences Corp (NASDAQ:AMBI) filed a lawsuit in effort to halt the proposed takeover of NASDAQ:AMBI stockholders should contact the Shareholders Foundation. San Diego, CA -- (ReleaseWire) -- ...Digital Journal, 1 week ago AMBIT BIOSCIENCES : NASDAQ:AMBI) Investor Alert: Lawsuit Filed to Halt Takeover by Daiichi Sankyo Company 4 Traders, 1 week ago
Document Format Files Seq Description Document Type Size 1 SC TO-T d800431dsctot.htm SC TO-T 45788 2 EX-99.(A)(1)(I) d800431dex99a1i.htm EX-99.(A)(1)(I) 471966 3 EX-99.(A)(1)(II) d800431dex99a1ii.htm EX-99.(A)(1)(II) 177960 4 EX-99.(A)(1)(III) ...SEC Filings, 1 week ago
Daiichi Sankyo-controlled Indian drug major Ranbaxy Laboratories Ltd, which awaits a regulatory clearance to go ahead with a proposed merger with Sun Pharma, has decided to settled the litigation concerning its participation in the Texas Medicaid ...VC Circle, 1 week ago 40 years ago and now: How Ranbaxy moved out of family control Rediff.com, 2 days ago 40 Years Ago... And now: Ranbaxy grew with liberal regimes, moving out of family control Business Standard India, 2 days ago
The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees cannot be lowered, it is learnt. Ranbaxy is said to ...Sify, 4 days ago Ranbaxy Laboratories??? Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd Buyout BioSpace, 3 days ago Sun Pharma posts Q1 profit on strong US sales The Financial Chronicle, 2 months ago
EQUITY ALERT: Rosen Law Firm Announces Investigation of Ambit Biosciences Corporation Concerning its Proposed Sale to Daiichi Sankyo Company, Ltd.
Company Website: http://rosenlegal.com/cases-381.html NEW YORK -- (Business Wire) The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Ambit Biosciences Corporation (NASDAQ:AMBI) for possible ...Stockwatch, 3 weeks ago Lifshitz & Miller Law Firm Announces Investigation of AcelRx Pharmaceuticals, Inc., Ambit Biosciences, Athlon.. ADVFN India, 2 weeks ago Athlon Energy : Lifshitz & Miller Law Firm : Announces Investigation of AcelRx Pharmaceuticals, Inc., Ambit Biosciences, Athlon Energy Inc., LipoScience, Inc., Simplicity Bancorp, Inc., and TIBCO Software Inc. 4 Traders, 2 weeks ago Ambit Biosciences : EQUITY ALERT: Rosen Law Firm Announces Investigation of Ambit Biosciences Corporation Concerning its Proposed Sale to Daiichi Sankyo Company, Ltd. 4 Traders, 3 weeks ago
More from: BioSpace, Stock Nod...and 40 other sources
on your WebpageAdd Widget >Get your members hooked!